21 Jan 2016 Mucosis Secures €3.7M from Wellcome Trust to Fund Clinical Trials of its Respiratory Syncytial Virus Vaccine in Partnership with Imperial College London
19 Jan 2016 Profectus BioSciences Initiates Ebola Vaccine Phase 1 Clinical Trial
12 Jan 2016 SELLAS Life Sciences Announces Preliminary Positive WT1 Cancer Vaccine Clinical Results in Multiple Myeloma Patients
12 Jan 2016 Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine
11 Jan 2016 Aimmune Therapeutics Enrolls First Patient in Phase 3 PALISADE Trial of AR101 for the Treatment of Peanut Allergy
08 Jan 2016 Dynavax Reports Top Line Results of Phase 3 HEPLISAV-B(TM) Study
05 Jan 2016 AiCuris’ AIC649 Shows Potential to Induce Functional Cure of Chronic Hepatitis B in Preclinical Study
04 Jan 2016 Yisheng Biopharma Announces Positive Results of Phase I Clinical Trial of a Novel Rabies Vaccine with PIKA Adjuvant
24 Dec 2015 CMV Vaccine Created at City of Hope is Found Safe, Effective in Patients Receiving Stem Cell Transplants
23 Dec 2015 World Health Organization to Review Merck’s Investigational Ebola Vaccine for Emergency Use Assessment and Listing
22 Dec 2015 Aduro Biotech Announces Initiation of Phase 1 Study of ADU-741 for the Treatment of Prostate Cancer
19 Dec 2015 Saronic Biotechnology Files Investigational New Drug Application With FDA for SBI1997 Phase I/II Clinical Trial
17 Dec 2015 Vaxart Announces Enrollment of First Patient in Influenza B Phase 1 Trial
17 Dec 2015 Aduro Biotech Receives Milestone Payment From Janssen for Acceptance of Investigational New Drug Application for ADU-741 in Prostate Cancer
16 Dec 2015 U.S. Food and Drug Administration Accepts Biologics License Application for PaxVax’s Single-Dose Oral Cholera Vaccine Vaxchora
16 Dec 2015 FDA Approves Expanded Age Indication for GARDASIL® 9 in Males
10 Dec 2015 ImmBio Initiates First-in-Human Studies of its Novel Pneumococcal Vaccine, PnuBioVax
08 Dec 2015 Medigene AG: Promising data from Phase I/II IIT and Compassionate Use Programme with dendritic cell vaccines in AML presented at ASH Annual Meeting 2015
08 Dec 2015 DBV Technologies Announces Initiation of Phase III Study of Viaskin(r) Peanut for the Treatment of Peanut Allergic Children
06 Dec 2015 Dynavax Presents Clinical Data From Lead Cancer Immunotherapy Candidate, SD-101, at ASH Annual Meeting
04 Dec 2015 Novavax Initiates Global Pivotal Phase 3 Trial of the RSV F Vaccine to Protect Infants via Maternal Immunization
02 Dec 2015 Immunovaccine's DPX-Survivac Induces an Immune Response in Diffuse Large B Cell Lymphoma
02 Dec 2015 NanoBio's Chlamydia Vaccine Improves Clearance of Bacteria and Prevents Pelvic Inflammatory Disease in Mice
01 Dec 2015 VALNEVA Reports Positive Phase II Results for its Clostridium Difficile Vaccine Candidate
30 Nov 2015 SELLAS Life Sciences Reports Positive WT1 Cancer Vaccine Clinical Results in Mesothelioma and Acute Myeloid Leukemia (AML) Patients at the Annual International WT1 Conference

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing